Morgan Stanley raised the target price for HKEX (00388) to HKD223 from HKD221 and maintained the "underweight" rating.
The research house said as HKEX has added more headcounts and adjusted payrolls, it raises total expense assumptions by 4.8%/4.5%/3.1% for 2024/2025/2026. These lead to lower EBITDA margin, down to 70.5% in 2024 from 72.3% in 2023.
【母親節限時優惠】 送價值$288維柏健30天逆轉肌齡(膠原蛋白+生物素) ► 火速行動